Protein detail

XYLT1

Xylosyltransferase 1 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase I) (XT-I) (XylT-I)

Entry name
XYLT1
UniProt ID
EVMP confidence score
0.72
Supporting publications (n)
16
Transmembrane count
1
Protein classification
Disease related genesEnzymesHuman disease related genesMetabolic proteinsPotential drug targetsPredicted intracellular proteinsPredicted secreted proteins
EVMP confidence score

Annotation confidence score; open for threshold definitions.

Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
Basic Information13
Protein Names
Xylosyltransferase 1 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase I) (XT-I) (XylT-I)
Protein Class (7)
Disease related genesEnzymesHuman disease related genesMetabolic proteinsPotential drug targetsPredicted intracellular proteinsPredicted secreted proteins
Protein Function (8)
  • Predicted intracellular proteins
  • Human disease related genes:Congenital malformations:Congenital malformations of the musculoskeletal system
  • ENZYME proteins:Transferases
  • Potential drug targets
  • Enzymes
  • Predicted secreted proteins
  • Human disease related genes:Congenital malformations:Congenital malformations of skin
  • Disease related genes
Transmembrane
18..38; Helical; Signal-anchor for type II membrane protein
Transmembrane Count
1
Entrez Gene Symbol
Gene Synonym (2)
PXYLT1XT-I
Gene Description
Xylosyltransferase 1
Chromosome
16
Position
17101769-17470960
Supporting publications (n)
16
EVMP confidence score
0.72
Fluorescence & Localization2
XYLT1 fluorescence
Cell SpecificPlatelets
Function & Pathway7
Protein Function (8)
  • Predicted intracellular proteins
  • Human disease related genes:Congenital malformations:Congenital malformations of the musculoskeletal system
  • ENZYME proteins:Transferases
  • Potential drug targets
  • Enzymes
  • Predicted secreted proteins
  • Human disease related genes:Congenital malformations:Congenital malformations of skin
  • Disease related genes
Mediation Categories
Metabolism mediation
Relations & Evidence21

Ligand-Receptor Signaling (16)

16 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
transmembranetransmembraneTopDBNoNoYesNoNo
transmembranetransmembraneOmniPathNoNoYesNoNo
secretedsecretedUniProt_keywordNoNoYesNoNo
secretedsecretedUniProt_locationNoNoYesNoNo
secretedsecretedHPA_secretomeNoNoYesNoNo
secretedsecretedOmniPathNoNoYesNoNo
Page 2 of 2Previous

Protein Complex Composition (4)

4 records.

Component NameComponent Gene SymbolsComponent UniProt IDStoichiometryDatabaseDatabase IDsReferences
Fukutin-FKRP-TMEM5 multienzyme complexFKRPFKTNRXYLT1O75072Q9H9S5Q9Y2B11:1:1ComplexPortalintact:EBI-402658392947784214755292
FKTNRXYLT1O75072Q9Y2B10:0hu.MAP2
SDC1XYLT1P18827Q86Y381:1PDBPDB:6eje
GALNT18GXYLT1Q4G148Q6P9A20:0hu.MAP

Isolation & Detection Technology (1)

1 record.

EV Isolation MethodDetection MethodNumber of ReferencesReferences
Differential UltracentrifugationDensity Gradient CentrifugationUltrafiltration / Tangential Flow FiltrationSize Exclusion ChromatographyMass spectrometry433204424377869183481790628986585
Sequence, Structure & Domains11

Sequences

Length
959
Mass
107,569
Sequence
MVAAPCARRLARRSHSALLAALTVLLLQTLVVWNFSSLDSGAGERRGGAAVGGGEQPPPAPAPRRERRDLPAEPAAARGGGGGGGGGGGGRGPQARARGGGPGEPRGQQPASRGALPARALDPHPSPLITLETQDGYFSHRPKEKVRTDSNNENSVPKDFENVDNSNFAPRTQKQKHQPELAKKPPSRQKELLKRKLEQQEKGKGHTFPGKGPGEVLPPGDRAAANSSHGKDVSRPPHARKTGGSSPETKYDQPPKCDISGKEAISALSRAKSKHCRQEIGETYCRHKLGLLMPEKVTRFCPLEGKANKNVQWDEDSVEYMPANPVRIAFVLVVHGRASRQLQRMFKAIYHKDHFYYIHVDKRSNYLHRQVLQVSRQYSNVRVTPWRMATIWGGASLLSTYLQSMRDLLEMTDWPWDFFINLSAADYPIRTNDQLVAFLSRYRDMNFLKSHGRDNARFIRKQGLDRLFLECDAHMWRLGDRRIPEGIAVDGGSDWFLLNRRFVEYVTFSTDDLVTKMKQFYSYTLLPAESFFHTVLENSPHCDTMVDNNLRITNWNRKLGCKCQYKHIVDWCGCSPNDFKPQDFHRFQQTARPTFFARKFEAVVNQEIIGQLDYYLYGNYPAGTPGLRSYWENVYDEPDGIHSLSDVTLTLYHSFARLGLRRAETSLHTDGENSCRYYPMGHPASVHLYFLADRFQGFLIKHHATNLAVSKLETLETWVMPKKVFKIASPPSDFGRLQFSEVGTDWDAKERLFRNFGGLLGPMDEPVGMQKWGKGPNVTVTVIWVDPVNVIAATYDILIESTAEFTHYKPPLNLPLRPGVWTVKILHHWVPVAETKFLVAPLTFSNRQPIKPEEALKLHNGPLRNAYMEQSFQSLNPVLSLPINPAQVEQARRNAASTGTALEGWLDSLVGGMWTAMDICATGPTACPVMQTCSQTAWSSFSPDPKSELGAVKPDGRLR

3D Structural Models

Turn
442..444; 463..465; 564..568; 602..604; 625..628; 707..710; 748..751; 876..880
Helix
262..270; 274..288; 315..318; 339..349; 365..377; 396..410; 432..441; 455..462; 500..508; 512..520; 521..523; 527..529; 531..538; 542..544; 557..560; 581..588; 607..617; 637..639; 641..643; 646..665; 852..859; 873..875; 885..895; 899..913; 933..935; 945..947
Beta Strand
303..305; 328..334; 354..360; 381..383; 417..422; 426..430; 446..448; 466..471; 474..480; 497..499; 545..547; 550..553; 569..571; 596..598; 629..636; 677..691; 694..706; 711..721; 737..747; 752..755; 767..772; 774..776; 778..785; 791..799; 805..808; 818..827; 830..839; 843..845; 865..870; 914..923; 936..939
3D Structure
X-ray crystallography (9)

Domain & Motif Annotations

Compositional Bias
78..104; Gly residues; 145..161; Basic and acidic residues; 163..172; Polar residues; 177..204; Basic and acidic residues; 249..259; Basic and acidic residues
Region
42..259; Disordered; 940..959; Disordered
Protein Families (2)
  • Glycosyltransferase 14 family
  • XylT subfamily
Sequence Similarities
Belongs to the glycosyltransferase 14 family. XylT subfamily.
Clinical Relevance2
Disease Involvement (2)
Disease variantDwarfism
Supporting Publications16
PMIDTitleAbstract
36398564Differential ultracentrifugation enables deep plasma proteomics through enrichment of extracellular vesicles.No abstract available
37205098Proteomic profiling of extracellular vesicles in synovial fluid and plasma from Oligoarticular Juvenile Idiopathic Arthritis patients reveals novel immunopathogenic biomarkers.No abstract available
37786918Rapid and in-depth proteomic profiling of small extracellular vesicles for ultralow samples.No abstract available
38321535Identification of specific markers for human pluripotent stem cell-derived small extracellular vesicles.No abstract available
39409015SILAC-Based Characterization of Plasma-Derived Extracellular Vesicles in Patients Undergoing Partial Hepatectomy.No abstract available
39766158A Proteomic Examination of Plasma Extracellular Vesicles Across Colorectal Cancer Stages Uncovers Biological Insights That Potentially Improve Prognosis.No abstract available
Page 2 of 2Previous